Welcome to our dedicated page for Nutanix SEC filings (Ticker: NTNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nutanix filings document material events for a cloud software company with Class A common stock and a subscription-based operating model. Recent 8-K disclosures cover operating and financial results, share repurchase authorizations, accelerated share repurchase activity, and a completed private placement of Class A common stock.
Governance filings address amended bylaws, stockholder meeting results, equity incentive plan changes, executive compensation arrangements and related capital-structure matters. These records also disclose material agreements, board actions and procedural changes affecting stockholder nominations, meeting authority, indemnification and equity compensation.
Insider Transaction Overview: Nutanix (NTNX) filed a Form 4 disclosing that President & CEO Rajiv Ramaswami sold 1,925 Class A common shares on 26 June 2025 at a reported price of $75 per share. The trade was executed automatically under a pre-arranged Rule 10b5-1 trading plan adopted 9 Sep 2024.
Post-Transaction Ownership: Following the sale, Ramaswami continues to hold 518,561 shares directly. The filing does not report any derivative transactions or changes to option positions.
Materiality Assessment: The divestiture is worth roughly $144,000, a de-minimis amount relative to the CEO’s remaining stake and Nutanix’s ~240 million shares outstanding. Because it was pre-scheduled, the transaction is generally viewed as routine and is unlikely to signal a shift in executive confidence.
Key Takeaways for Investors:
- Sale size represents less than 0.4% of the executive’s direct holdings.
- Use of a 10b5-1 plan limits potential concerns about timing or insider knowledge.
- No additional insider sales or option exercises were reported.
Nutanix, Inc. (NTNX) filed a Form 144 signaling a proposed insider sale by President & CEO Rajiv Ramaswami, who also serves as a director. The notice covers the potential disposition of 1,925 common shares—acquired as restricted stock on 15-Jun-2025—through Morgan Stanley Smith Barney, with an estimated market value of $144,375. The transaction is expected to occur on, or about, 26-Jun-2025 on the Nasdaq.
The filing discloses that approximately 268.1 million shares of Nutanix common stock are outstanding, so the size of the contemplated sale represents less than 0.001 % of shares outstanding and is therefore immaterial from a capitalization standpoint. Ramaswami adopted or amended a Rule 10b5-1 trading plan on 09-Sep-2024, which provides an affirmative defense against insider-trading allegations by automating trade execution.
Form 144 also lists recent insider activity: Ramaswami sold a total of 61,057 shares on 13-May-2025 for aggregate gross proceeds of roughly $4.82 million. Although insider sales do not automatically imply negative fundamentals, investors often track selling cadence to gauge executive sentiment. Given the minor size of the new sale and its compliance with a pre-arranged plan, the near-term market impact is likely negligible.